How can we assess the risk for sudden cardiac death to decide for primary prophylactic implantable cardioverter-defibrillator in patients with heart failure in 2022?
This website uses cookies to ensure that visitors get the best experience. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy
